Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
- Resource Type
- article
- Source
- Trials, Vol 21, Iss 1, Pp 1-1 (2020)
- Subject
Medicine (General) R5-920 - Language
- English
- ISSN
- 1745-6215